Globalpharma has been inspected by UAE Ministry of Health Senior Officials
GlobalPharma, an entirely subsidiary of Dubai Investments PJSC, facilitated His Excellency Dr Amin Hussain Al Amiri, Assistant Undersecretary for Medical Practice and License Sector in the UAE Ministry of Health and Chairman of the UAE Supreme National Blood Transfusion Committee, and his accompanying with Dr Ruqaya Al Bastaki, Director of Drug Department, Ministry of Health and Prevention (MoHAP); and Dr Rita Al Shalouhi, Expert in Pharmaceutical Policies; to the facility situated at Dubai Investment Park (DIP).
Abdulaziz Bin Yagub Al Serkal, CEO of Industrial Platform - Dubai Investments PJSC; alongside Dr Bassem Albarameh, Acting General Manager of Globalpharma; Dr Idrees Siddiqui, Director of the Globalpharma Site; and Mohamed Alloush, Director of Regulatory Affairs and Registration; invited the authorities to the Globalpharma office.
The review visit, some portion of MoHAP's methodology, planned for actualizing national principles, fortifying, monitoring, and managing the role of medical and pharmaceutical organizations, and strengthening the role of investigation by expanding the quantity of legal auditors the nation over.
As a feature of the examination visit, HE Dr Amin talked about the organization's tentative arrangements for the headway of the pharmaceutical business in the nation and ways and territories of participation with the Ministry of Health to advance and create aspiring plans in accordance with UAE Vision 2030.
His Excellency included: "The local government is glad for the country and the resident. It is time that an Emirati citizen, with his experience and effectiveness, finds the ideal spot in this significant area to accomplish success and improvement."
The adaptability of the MoHAP's assessment groups managing the health facilities and local production facilities, just as their consistent correspondence with them, causes increment the adherence to laws and improve the soul of obligation and self-oversight among manufacturers and healthcare facilites.
MoHAP stressed on the significance of exports, urging local factories to upgrade sending out to different nations so the UAE drug is accessible over all countries of the region, improving the national economy.
